Dxn Holdings
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dxn Holdings - overview
Established
1993
Location
Alor Setar, -, Malaysia
Primary Industry
Food
About
Dxn Holdings is a health and wellness company that specializes in herbal supplements and personal care products, utilizing the medicinal properties of Ganoderma lucidum to promote wellness and vitality. Founded in 1993 in Alor Setar, Malaysia, Dxn Holdings operates primarily in the health and wellness sector, focusing on herbal supplements and dietary products. The company's founder has a history in the wellness industry, although specific details of prior ventures are not disclosed. Dxn Holdings received significant funding in May 2017 from KV Asia Capital, which acquired a substantial equity stake.
DXN2U offers a comprehensive range of health and wellness products, emphasizing herbal supplements, dietary items, and personal care goods that harness the benefits of Ganoderma lucidum, also known as reishi mushroom. The products are designed to support various health objectives, targeting health-conscious consumers, fitness enthusiasts, and those seeking alternative remedies. The company's distribution strategy spans multiple regions, including North America, Europe, Asia, and parts of the Middle East, utilizing both direct-to-consumer sales and partnerships with local retailers. In the most recent financial year, Dxn Holdings reported a revenue of USD 390.
38 mn and an EBITDA of USD 116. 24 mn. The company's revenue is generated through a combination of direct-to-consumer sales and B2B partnerships, facilitated by e-commerce platforms and authorized distributors who expand market reach. Dxn Holdings is actively planning to introduce new products aimed at enhancing their wellness offerings, with detailed launch timelines to be announced.
The company is also targeting expansion into new markets, specifically focusing on increasing its presence in emerging regions by 2025. The investment received from KV Asia Capital in May 2017 will likely support these growth initiatives, allowing Dxn Holdings to enhance product development and market expansion efforts.
Current Investors
KV Asia Capital
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements
Website
https://www.dxn2u.com/home.php
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Dxn Holdings - timeline of key events
Dxn Holdings - financials
| Fiscal Year Ended | Feb 28, 2011 | Feb 29, 2012 | Feb 28, 2013 | Feb 28, 2014 | Feb 28, 2015 | Feb 29, 2016 | Feb 28, 2017 | Feb 28, 2018 | Feb 28, 2019 | Feb 29, 2020 | Feb 28, 2021 | Feb 28, 2022 | Feb 28, 2023 | Feb 29, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 279,339,100 | 268,555,598 | 269,121,474 | 311,692,395 | 353,102,121 | 476,157,644 | 634,653,744 | 804,464,052 | 967,426,882 | 1,113,572,000 | 1,050,205,000 | - | - | - |
| % Revenue Growth (YoY) | - | (3.9%) | 0.2% | 15.8% | 13.3% | 34.8% | 33.3% | 26.8% | 20.3% | 15.1% | (5.7%) | - | - | - |
| EBITDA (USD) | 62,325,866 | 67,497,745 | 62,734,915 | 85,411,240 | 86,689,892 | 99,971,119 | 156,373,667 | 200,599,365 | 330,325,560 | 381,421,000 | 313,858,000 | - | - | - |
| Operating Income (USD) | 55,393,745 | 59,558,147 | 55,007,119 | 78,442,702 | 79,017,536 | 90,919,912 | 145,728,879 | 188,507,641 | 316,515,162 | 356,292,000 | 282,832,000 | - | - | - |
| Operating Margin | 19.8% | 22.2% | 20.4% | 25.2% | 22.4% | 19.1% | 23.0% | 23.4% | 32.7% | 32.0% | 26.9% | - | - | - |
| % EBITDA Margin | 22.3% | 25.1% | 23.3% | 27.4% | 24.6% | 21.0% | 24.6% | 24.9% | 34.1% | 34.3% | 29.9% | - | - | - |
| NET Income (USD) | 41,825,746 | 45,510,811 | 42,557,110 | 56,772,819 | 57,740,729 | 64,102,333 | 97,556,909 | 128,269,457 | 221,559,611 | 266,250,000 | 200,884,000 | - | - | - |
| % Net Margin | 15.0% | 16.9% | 15.8% | 18.2% | 16.4% | 13.5% | 15.4% | 15.9% | 22.9% | 23.9% | 19.1% | - | - | - |
Dxn Holdings - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Dxn Holdings | - |
Displaying 1 - 1 of 1
Dxn Holdings - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.